Alison Ives was appointed Executive Vice President and Chief Scientific Officer in June 2022. Ms. Ives previously served in roles of increasing responsibility, including Vice President Regulatory Affairs, Consumer Self-Care International from December 2017 to September 2020 and Vice President, Consumer Self-Care Americas, from September 2020 until May 2022. Ms. Ives joined Perrigo through the acquisition of Omega Pharma, where she worked for five years building a Regulatory Affairs function and new product pipeline. Ms. Ives also worked with AstraZeneca for 11 years in a variety of regional and global leadership roles within the Scientific office, while sitting on new product development teams across five therapeutic areas. Her career achievements have been recognized externally by receiving a prestigious MBE award from the UK government for services to healthcare, reflecting her lifelong passion to make lives better.